Tirzepatide Prescribing at MOAT HOUSE SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
195
Total Quantity
213
NHS Cost
£20.2K
vs National Avg
+0.4%
MOAT HOUSE SURGERY prescribed 195 items of Tirzepatide over the last 12 months at a cost of £20,158 to the NHS. This is 0.4% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
1
Jul 2026
7
Jul 2026
12
Jul 2026
18
Jul 2026
22
Jul 2026
23
Jul 2026
25
Jul 2026
27
Jul 2026
31
Jul 2026
29
Prescribing Details
| Total Items | 195 |
|---|---|
| Total Quantity | 213 |
| Total NHS Cost | £20,158 |
| Presentations | 9 different forms |
| vs National Average | +0.4% |
Tirzepatide Prescribing Comparison
| This practice | 195 items |
|---|---|
| National average per practice | 194 items |
| Difference | +0.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.